Chiesi Pharmaceuticals

• NCT06268769

  Collaborator, Phase 4, Recruiting, 300 people, 20 Feb 2024

• NCT04720326

  Collaborator, Phase 4, Active, not recruiting, 268 people, 22 Jan 2021

• Supervised multimodal prehabilitation of older patients with frailty or prefrailty before elective surgery: a multicentre randomised controlled outcome assessor-blinded trial

  Fees or honoraria, 15 Sept 2026

• Incidence of Dementia in Older Adults Hospitalized With Acute Coronary Syndrome: Insights From KP-Brain-Heart Health Study

  Board or leadership role, 28 Aug 2026

• Primary results of the VICTORION-NOVEL (LDL-C management Program in atherosclerotic cardiovascular disease patients with elevated LDL-C) lipid optimization multicenter implementation trial

  Consulting or advice, Grants or research support, Board or leadership role, 16 Jul 2026

• Cancer risk in patients with pulmonary fibrosis and a rare telomere related gene variant

  Fees or honoraria, 19 Jan 2026

Sources: pubmed.ncbi.nlm.nih.gov